Citigroup resumed coverage on Medline with a new price target
$MDLN
Medical/Dental Instruments
Health Care
Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/11/2026 | $60.00 | Buy | Citigroup |
| 2/5/2026 | $55.00 | Buy | Tigress Financial |
| 1/21/2026 | $50.00 → $55.00 | Buy | BTIG Research |
| 1/12/2026 | $48.00 | Buy | Citigroup |
| 1/12/2026 | $38.00 | Neutral | BNP Paribas Exane |
| 1/12/2026 | $50.00 | Overweight | Analyst |
| 1/12/2026 | $50.00 | Overweight | Piper Sandler |
| 1/12/2026 | $48.00 | Overweight | Morgan Stanley |
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
424B4 - Medline Inc. (0002046386) (Filer)
EFFECT - Medline Inc. (0002046386) (Filer)
S-1 - Medline Inc. (0002046386) (Filer)
Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00
Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00
BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
NORTHFIELD, Ill., April 3, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Golden Cone Awards to its top-performing manufacturing facilities in the U.S. These awards recognize Medline's seventeen manufacturing facilities in the United States across three size tiers based on employee count and hours worked, and are evaluated using monthly safety metrics, employee engagement in safety advocacy and awareness, and execution of an annual safety plan. Medline de
Awards selection is highest recognition for healthcare supply chain partnershipNORTHFIELD, Ill., April 1, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced today it was awarded two supply chain recognitions by the Healthcare Industry Resiliency Collaborative (HIRC), a neutral, nonprofit standardization organization that gives healthcare organizations tools to measure, compare and strengthen supply chain resiliency. Medline earned the HIRC Highest Member Choice Award for S
Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growthNORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced during a groundbreaking event this week that it plans to expand its national network of 45 distribution centers across the U.S. by constructing a new 1.2 million sq. ft. distribution center in Midlothian, Texas. The distribution center is to be fully operational in Q2 of 2027 and is the first new DC announced by Medline in 2026 and after its initial public offering in December of last year.
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli